Intra-Cellular Therapies (ITCI.MX) Q1 2024 Earnings

22FebConfirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-10.55
-8.5
-6.44
-4.38

Details

Expected EPS
-7.693110000000001
Actual EPS
-5.12874
Surprise EPS
2.56
Surprise Percent
+33.33%

Description

Intra-Cellular Therapies (ITCI.MX) has reported earnings of -5.12874 per share for Q1 2024.

0 Comments

Share your thoughts